Intravenous (IV) use is less common and only done in clinical settings
Angiogenic support encourages small vessel growth, which brings nutrients to areas that often lag behind circulation
fluid build-up in or around the lungs - pain when you breathe, feeling short of breath while lying down, wheezing, gasping for breath, cough with foamy mucus, cold and clammy skin, anxiety, rapid heartbeats
It lowers the concentration, which means you draw a larger volume per dose
The two-phase approach is standard because: Loading phase builds up tissue saturation quickly - cells need adequate TB-500 present to initiate the full repair cascade Maintenance phase sustains that saturation at lower cost while healing progresses - full loading doses indefinitely aren't needed or beneficial Skipping the loading phase by jumping straight to maintenance doses is the most common TB-500 dosing mistake - you never build adequate tissue concentrations and results are poor
Animal studies are promising, showing enhanced healing of connective tissue and protective effects on the digestive tract